Chronic Non-Cancer Pain
16
4
5
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
Preventive Interventions for Chronic Pain Worsening
Multidisciplinary Intervention for Non-Cancer Chronic Pain: Pilot Study
Personalized Care Management Model (GAP-421) for Chronic Pain in Primary Care Physiotherapy
Pre-habilitation Interventions to Empower Patients With Chronic Pain
Scool of Pain (SchooP): A Way to Create Value in Healthcare?
Test-retest and Experiences During Balance Assessment With the Mini-BESTest
Chronic Insomnia in Non-Cancer Pain Patients
Music as an Adjunct to Ketamine Therapy for Chronic Pain
Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Chronic Non-cancer Pain
Exploring Long-term Pain Relief with 5% Dextrose Added to Local Anesthetic
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain
Cannabis Oil for Chronic Non-Cancer Pain Treatment
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
Pilot Trial of Opioid Taper Support
Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care